UNCY (Unicycive Therapeutics) OCF Margin %: 0.00% (As of Mar. 2026)


UNCY Unicycive Therapeutics Inc UNCY
30 GF Score
Price $5.73
! 2 Warning Signs
View Full Analysis

What is Unicycive Therapeutics OCF Margin %?

Unicycive Therapeutics UNCY +8.52% 30 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates UNCY with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 954 Biotechnology companies, Unicycive Therapeutics ranks worse than 104821.7% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Unicycive Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-6.24 Mil. Unicycive Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Unicycive Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Unicycive Therapeutics's current OCF Yield % is -18.26%.

The historical rank and industry rank for Unicycive Therapeutics's OCF Margin % or its related term are showing as below:


During the past 7 years, the highest OCF Margin % of Unicycive Therapeutics was -1645.74%. The lowest was -2708.59%. And the median was -2177.17%.

UNCY's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -65.71
* Ranked among companies with meaningful OCF Margin % only.

Unicycive Therapeutics OCF Margin % Related Terms

Unicycive Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Unicycive Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unicycive Therapeutics OCF Margin % Chart

Unicycive Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial 0.00 -1,645.74 -2,708.59 0.00 0.00

Unicycive Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
UNCY
30GF Score
Unicycive Therapeutics Inc UNCY
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unicycive Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Unicycive Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-31.317/0
= %

Unicycive Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-6.241/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Unicycive Therapeutics (UNCY) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Unicycive Therapeutics and its competitors. According to the industry distribution chart, Unicycive Therapeutics ranks #999999 out of 954 companies in the Biotechnology industry.
Is Unicycive Therapeutics' OCF Margin % too high?
Unicycive Therapeutics' current OCF Margin % is 0.00%. Based on the distribution chart, Unicycive Therapeutics ranks #999999 out of 954 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Unicycive Therapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Unicycive Therapeutics' OCF Margin % compare to MDWD and ARCT?
According to the Biotechnology industry distribution chart, Unicycive Therapeutics ranks #999999 out of 954 companies for OCF Margin %. This places Unicycive Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Unicycive Therapeutics and its competitors. Unicycive Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unicycive Therapeutics stock overvalued right now?
Unicycive Therapeutics (UNCY) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Unicycive Therapeutics' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Unicycive Therapeutics (UNCY), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Unicycive Therapeutics Business Description

Address 1975 W. El Camino Real, Suite 204, Mountain View, CA, USA, 94040
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
30GF Score

Get the complete analysis for UNCY

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.73
Price